Man Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.88M Sell
129,384
-218,776
-63% -$5.23M 0.01% 1409
2025
Q4
$9.3M Sell
348,160
-29,013
-8% -$693K 0.02% 832
2025
Q3
$8.05M Buy
377,173
+90,240
+31% +$2.13M 0.02% 883
2025
Q2
$6.19M Buy
286,933
+90,615
+46% +$1.68M 0.01% 969
2025
Q1
$3.26M Sell
196,318
-1,024,704
-84% -$18.6M 0.01% 1180
2024
Q4
$22.4M Sell
1,221,022
-54,411
-4% -$878K 0.07% 388
2024
Q3
$19.6M Buy
1,275,433
+1,218,288
+2,132% +$20.3M 0.06% 461
2024
Q2
$929K Buy
57,145
+6,844
+14% +$110K ﹤0.01% 1533
2024
Q1
$930K Buy
50,301
+18,081
+56% +$448K ﹤0.01% 1571
2023
Q4
$1.01M Buy
+32,220
New +$769K ﹤0.01% 1444
2023
Q3
Sell
-277,196
Closed -$7.53M 1217
2023
Q2
$6.64M Buy
+277,196
New +$6.16M 0.02% 765
2023
Q1
Sell
-955,688
Closed -$18.2M 472
2022
Q4
$15.2M Buy
955,688
+932,503
+4,022% +$14.6M 0.05% 415
2022
Q3
$379K Buy
+23,185
New +$375K ﹤0.01% 1600
2022
Q2
Sell
-19,436
Closed -$470K 2024
2022
Q1
$470K Buy
+19,436
New +$470K ﹤0.01% 1602
2021
Q1
Sell
-50,129
Closed -$2.68M 1829
2020
Q4
$2.68M Sell
50,129
-9,131
-15% -$453K 0.01% 1087
2020
Q3
$2.44M Sell
59,260
-56,160
-49% -$2.43M 0.01% 1124
2020
Q2
$5.59M Buy
115,420
+65,835
+133% +$3.16M 0.03% 612
2020
Q1
$2.1M Sell
49,585
-37,732
-43% -$1.55M 0.01% 867
2019
Q4
$3.73M Buy
+87,317
New +$3.8M 0.01% 1104
2019
Q2
Sell
-48,215
Closed -$1.29M 1867
2019
Q1
$1.29M Sell
48,215
-1,646
-3% -$38.4K ﹤0.01% 1497
2018
Q4
$806K Buy
+49,861
New +$968K ﹤0.01% 1520
2018
Q2
Sell
-6,314
Closed -$142K 2093
2018
Q1
$142K Buy
+6,314
New +$175K ﹤0.01% 1947

Other funds holding ACAD